DOSSIER · 13F Holders · Q2 2026
MAZE
MAZE THERAPEUTICS INC
165 institutions still hold MAZE THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 578784100·165 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
165 institutions reported MAZE in Q2 2026. Frazier Life Sciences Management, L.P. leads at 11.4% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 9
145 more holders available. Log in →